Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB-GXBM vs GLYBURIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLOFITAMAB-GXBM vs GLYBURIDE: Safety Overview

Metric GLOFITAMAB-GXBM GLYBURIDE
Total FAERS Reports 498 2,143
Deaths Reported 175 283
Death Rate 35.1% 13.2%
Hospitalizations 113 928
Average Patient Age 60.0 yrs 63.9 yrs
% Female Patients 36.2% 54.0%
FDA Approval Date N/A Apr 14, 2016
Manufacturer N/A Teva Pharmaceuticals USA, Inc.
Route N/A ORAL
Marketing Status Prescription Discontinued